Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous paracetamol for patent ductus arteriosus closure in preterm infants
IRCT20261024071550N1Phase 3Not yet recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Demographic data, Hemodynamic assessment indices and 3 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20261024071550N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261024071550N1.